Hyperpigmentation Disorders Treatment Market Analysis and Outlook Report

[Pavan Ishi]

Transparency Market Research (TMR) has published a new report titled ‘Hyperpigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global hyperpigmentation disorders treatment market was valued at US$ 3,947.3 Mn in 2017 and is projected to reach US$ 7,225.6 Mn by 2026, expanding at a CAGR of 7.2% during the forecast period from 2018 to 2026. The report suggests that augmented adoption of lasers in hyperpigmentation disorders treatment, decrease in social taboos boosting acceptance of pigmentation disorders treatment measures, increase in prevalence of pigmentation related disorders, rise in awareness about skin rejuvenation, improving lifestyle, and increasing disposable income are likely to drive the hyperpigmentation disorders treatment market from 2018 to 2026.

Request a Sample of Hyperpigmentation Disorders Treatment Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S...

Despite its considerable patient population globally, the hyperpigmentation disorders treatment market has often been overlooked and has remained stagnant for the past few decades, with no novel drugs entering the arena. The lack of dedicated research programs has been attributed to pharmaceutical companies viewing topicals, the mainstay of hyperpigmentation disorders treatment therapy, as being inexpensive with a poor return on investment. Instead, the market has shifted towards reformulations of existing products and/or fixed-dose combination therapies. Examples of the latter include combination products by key dermatology players, such as Galderma’s Tri-Luma (fluocinolone acetonide/hydroquinone/tretinoin).

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B...

Innovative products in hyperpigmentation disorders should focus on cost-effectiveness, potential to improve compliance. The biggest unmet needs in hyperpigmentation disorders include the need for new and innovative products, for improved compliance, and for less expensive products relative to existing therapies. Historically, pharmaceutical companies have been reluctant to enter the hyperpigmentation disorders market due to the poor return on investment in this competitive landscape. This attitude has inhibited progress toward developing disease-modifying agents, and agents with more long-lasting effects. However, the hyperpigmentation disorders treatment landscape is expected to change in the near to long term, with the use of laser and phototherapy, and additional companies involved in research for innovative acne products.

Request for Analysis of COVID19 Impact on Hyperpigmentation Disorders Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=c...

The report offers detailed segmentation of the global hyperpigmentation disorders treatment market based on treatment type, disease indication, end-user, and region. In terms of treatment type, the topical drugs segment is estimated to account for a large share of the market. An increasing number of patients with hyperpigmentation disorders are visiting dermatologists, and topical drugs are being prescribed to these patients.

Topical Drugs to Account for Major Share

The topical drug segment is expected to account for a leading share of the market in 2026. The segment is also likely to expand at a rapid pace during the forecast period. Rapid growth in the incidence rate of hyperpigmentation disorders across the globe will lead to an increased number of patients who will undergo diagnosis in the form of topical drugs and chemical peel, as well as treatment using techniques such as laser and phototherapy. This will in turn increase the uptake of hyperpigmentation disorders treatment, thereby driving growth of the market.

Enquiry before Buying Hyperpigmentation Disorders Treatment Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=E...

Key Players such as ALLERGAN, Galderma S.A., and SkinCeuticals to Lead the Market

The report also provides profiles of leading players operating in the global hyperpigmentation disorders treatment market. They include include Bayer AG, ALLERGAN, Galderma S.A., SkinCeuticals, Pierre Fabre, EpiPharm AG, RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC, and Vivier Pharma. Corporate trend is the strategic acquisition of key dermatology products by Big Pharma. A notable event in 2009 involved the acquisition of Stiefel, a leading dermatology company, by GSK for $3.6 billion.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/increase-in-smart-use-of-t...

https://www.prnewswire.co.uk/news-releases/continuous-r-amp-d-to-ex...

https://www.prnewswire.com/news-releases/dental-cements-market-to-b...

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: [phone]
USA – Canada Toll Free: 866-552-3453
Email: [e-mail]

Website: https://www.transparencymarketresearch.com/